Venture Life (VLG:32.5p), a Bracknell-based company that develops, manufactures and distributes products for the self-care market (including medical devices, food supplements, and dermo-cosmetics), entered 2020 with an order book up 40 per cent year on year.
Since then the company has completed the acquisition of PharmaSource, a Netherlands-based distribution business that owns a number of medical device products in key therapeutic areas (fungal nail infections, wart removal and women's health). The products are distributed through retail pharmacies in the Netherlands and through key international distribution partners in the UK, Germany, the Nordics, Belgium and France.
Strategically, the acquisition broadens Venture’s product range, extends its global reach by providing additional retailers and distribution partners to boost the company’s existing network of over 100 distributors across 44 countries, and offers cross-selling opportunities. There is also potential for Venture to bring the manufacturing of PharmaSource’s in-house to its own facilities in Italy, thus improving the brand’s cost of sales.